Oncology

Balancing Efficacy, Safety, and Cost in Formulary Decisions for Cell and Gene Therapies: Clayton Irvine, PharmD, MBA, MS

Balancing Cost, Coverage, and Clinical Value in First-Line Multiple Myeloma Care: Emilie Aschenbrenner, PharmD, BCOP

A Pharmacist’s Perspective on Optimizing Therapy Selection and Deprescribing in Oncology: Jason Bergsbaken, PharmD, MBA, BCOP

Integrating AI and Pathway Flexibility to Advance Value-Based Cancer Care: Clayton Irvine, PharmD, MBA, MS

Optimizing Oncology Care Through Academic–Community Partnerships and Real-World Evidence: Clayton Irvine, PharmD, MBA, MS

Navigating Biosimilar Mandates and Prior Authorization in a Value-Based Cancer Care Model: Jason Bergsbaken, PharmD, MBA, BCOP

Academic–Community Partnerships and Real-World Data in Value-Based Oncology: Jason Bergsbaken, PharmD, MBA, BCOP

Linvoseltamab May Bring Multiple Myeloma Care Closer to Home: Sundar Jagannath, MBBS

The Role of Real-World Data in Advancing Value-Based Cancer Care: CK Wang, MD

Clinicians Should Be Able to Rely on Coverage for Category 2B Treatments: Eric Lander, MD

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions

Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic

Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman

Oncology Onward: A Conversation With OneOncology’s Dr Jeff Patton

Health Equity Conversations: Improving Diversity of Oncology Care Staff

Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity

Reforming Oncology Care Payments: Interviews From the QCCA Leadership Summit

What Are the Next Steps for Collaboration, Accountability in Oncology Care First?

KOL Corner: Amy Ellis Discusses Value-Based Cancer Rehab With Amanda Hodges